Unity Biotechnology Upgraded - Analyst Highlights Cash Strength & Execution

By: via Benzinga
Wedbushanalyst Andreas Argyrides upgraded the shares ofUnity Biotechnology Inc(NASDAQ: UBX) from Neutral to Outperform ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.